| pubmed-article:11083512 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:11083512 | lifeskim:mentions | umls-concept:C0162638 | lld:lifeskim |
| pubmed-article:11083512 | lifeskim:mentions | umls-concept:C0376669 | lld:lifeskim |
| pubmed-article:11083512 | lifeskim:mentions | umls-concept:C2349943 | lld:lifeskim |
| pubmed-article:11083512 | pubmed:issue | 5 | lld:pubmed |
| pubmed-article:11083512 | pubmed:dateCreated | 2001-2-20 | lld:pubmed |
| pubmed-article:11083512 | pubmed:abstractText | To investigate possible associations of soluble CD95 (sCD95) serum levels and DNA defragmentation with different MS disease stages and activities. | lld:pubmed |
| pubmed-article:11083512 | pubmed:language | eng | lld:pubmed |
| pubmed-article:11083512 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11083512 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:11083512 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11083512 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11083512 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:11083512 | pubmed:month | Nov | lld:pubmed |
| pubmed-article:11083512 | pubmed:issn | 0001-6314 | lld:pubmed |
| pubmed-article:11083512 | pubmed:author | pubmed-author:HeesenCC | lld:pubmed |
| pubmed-article:11083512 | pubmed:author | pubmed-author:SchoserB GBG | lld:pubmed |
| pubmed-article:11083512 | pubmed:author | pubmed-author:GbadamosiJJ | lld:pubmed |
| pubmed-article:11083512 | pubmed:author | pubmed-author:GeorghiuSS | lld:pubmed |
| pubmed-article:11083512 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:11083512 | pubmed:volume | 102 | lld:pubmed |
| pubmed-article:11083512 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:11083512 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:11083512 | pubmed:pagination | 333-6 | lld:pubmed |
| pubmed-article:11083512 | pubmed:dateRevised | 2006-8-16 | lld:pubmed |
| pubmed-article:11083512 | pubmed:meshHeading | pubmed-meshheading:11083512... | lld:pubmed |
| pubmed-article:11083512 | pubmed:meshHeading | pubmed-meshheading:11083512... | lld:pubmed |
| pubmed-article:11083512 | pubmed:meshHeading | pubmed-meshheading:11083512... | lld:pubmed |
| pubmed-article:11083512 | pubmed:meshHeading | pubmed-meshheading:11083512... | lld:pubmed |
| pubmed-article:11083512 | pubmed:meshHeading | pubmed-meshheading:11083512... | lld:pubmed |
| pubmed-article:11083512 | pubmed:meshHeading | pubmed-meshheading:11083512... | lld:pubmed |
| pubmed-article:11083512 | pubmed:meshHeading | pubmed-meshheading:11083512... | lld:pubmed |
| pubmed-article:11083512 | pubmed:meshHeading | pubmed-meshheading:11083512... | lld:pubmed |
| pubmed-article:11083512 | pubmed:meshHeading | pubmed-meshheading:11083512... | lld:pubmed |
| pubmed-article:11083512 | pubmed:meshHeading | pubmed-meshheading:11083512... | lld:pubmed |
| pubmed-article:11083512 | pubmed:meshHeading | pubmed-meshheading:11083512... | lld:pubmed |
| pubmed-article:11083512 | pubmed:meshHeading | pubmed-meshheading:11083512... | lld:pubmed |
| pubmed-article:11083512 | pubmed:meshHeading | pubmed-meshheading:11083512... | lld:pubmed |
| pubmed-article:11083512 | pubmed:meshHeading | pubmed-meshheading:11083512... | lld:pubmed |
| pubmed-article:11083512 | pubmed:year | 2000 | lld:pubmed |
| pubmed-article:11083512 | pubmed:articleTitle | CD95-mediated apoptosis and DNA fragmentation in MS. | lld:pubmed |
| pubmed-article:11083512 | pubmed:affiliation | Department of Neurology, University of Hamburg, Germany. heesen@uke.uni-hamburg.de | lld:pubmed |
| pubmed-article:11083512 | pubmed:publicationType | Journal Article | lld:pubmed |
